Related references
Note: Only part of the references are listed.Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Gene expression of O-GlcNAc cycling enzymes in human breast cancers
Anna Krzeslak et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2012)
Critical Role of O-Linked β-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis
Thomas P. Lynch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation
Qianqian Zhu et al.
MEDICAL ONCOLOGY (2012)
Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease
Gerald W. Hart et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy
Wenyi Mi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells
Tracey M. Gloster et al.
NATURE CHEMICAL BIOLOGY (2011)
Downregulation of nuclear factor-κB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer
Rui Kong et al.
CANCER LETTERS (2010)
NF-κB promotes epithelial-mesenchynmal transition, migration and invasion of pancreatic carcinoma cells
Harald J. Maier et al.
CANCER LETTERS (2010)
Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition
Sang Yoon Park et al.
EMBO JOURNAL (2010)
Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia
Y. Shi et al.
LEUKEMIA (2010)
Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1
S. A. Caldwell et al.
ONCOGENE (2010)
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Heehyoung Lee et al.
CANCER CELL (2009)
CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models
W. Schneiderhan et al.
GUT (2009)
Tumor Necrosis Factor-α Induces RelA Degradation via Ubiquitination at Lysine 195 to Prevent Excessive Nuclear Factor-κB Activation
Yihui Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification
Keiko Kawauchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity
Mohan R. Kaadige et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Maintenance of constitutive IκB kinase activity by glycogen synthase kinase-3α/β in pancreatic cancer
Willie Wilson et al.
CANCER RESEARCH (2008)
Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
Ralph J. DeBerardinis
GENETICS IN MEDICINE (2008)
P53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
Keiko Kawauchi et al.
NATURE CELL BIOLOGY (2008)
NFκB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions
Won Ho Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling
Rehan Ahmad et al.
NATURE CELL BIOLOGY (2007)
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Mariia Yuneva et al.
JOURNAL OF CELL BIOLOGY (2007)
Chemotherapy for pancreatic cancer: From metastatic disease to adjuvant therapy
Robert A. Wolff
CANCER JOURNAL (2007)
Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy
Gauri R. Varadhachary et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor κB signaling
Qing Ren et al.
CANCER RESEARCH (2006)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
O-GlcNAcase uses substrate-assisted catalysis -: Kinetic analysis and development of highly selective mechanism-inspired inhibitors
MS Macauley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression
JC Maher et al.
PANCREAS (2005)
被撤回的出版物: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells (Retracted article. See FEB, 2023)
MS Duxbury et al.
ONCOGENE (2004)
被撤回的出版物: Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity (Retracted article. See vol. 173, pg. 1108, 2023)
H Ito et al.
SURGERY (2004)
Mitogenic and antiapoptotic role of constitutive NF-κB/Rel activity in pancreatic cancer
S Liptay et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance
L Wells et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation
LR James et al.
DIABETES (2002)
Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine
FI Comer et al.
ANALYTICAL BIOCHEMISTRY (2001)
Share Paper
